A synthetic yeast platform, dubbed osteoyeast, that efficiently converts human urine into high-value hydroxyapatite. This sustainable biomanufacturing process provides a cost-effective alternative to traditional production methods for medical-grade bone and dental biomaterials while simultaneously supporting wastewater nutrient recovery. The technology is patent-pending and available for commercial licensing or collaborative research.
The osteoyeast platform is a synthetic biology innovation that transforms human urine into high-value hydroxyapatite (HAp), a calcium phosphate biomaterial essential for bone and dental restoration. By genetically engineering the yeast species Saccharomyces boulardii, researchers have created a cost-effective, sustainable biomanufacturing method that mimics the natural mineralization processes of human osteoblast cells. This technology addresses the dual challenge of waste management and resource scarcity by turning a typically discarded byproduct into a valuable commodity, with potential applications ranging from medical implants to environmentally friendly construction materials.
The technology has reached the proven principle stage, with successful lab-scale validation of HAp production from urine published in peer-reviewed literature. It is currently patent pending and available for licensing or collaborative research through the Berkeley Lab Intellectual Property Office. Assessment: 3.
Berkeley Lab is a multi‑program U.S. Department of Energy national laboratory in Berkeley, operated by the University of California. Industry engages through open scientific user facilities, national high‑performance computing, co‑located nanoscience and materials characterization labs, and testbeds, with options for nonproprietary and, where permitted, proprietary work. Proximity to UC Berkeley and the Bay Area innovation ecosystem enables joint appointments, sponsored research, and talent pipelines via CRADAs and Strategic Partnership Projects. Research is funded primarily by the DOE Office of Science, with additional competitive support from other federal agencies and industry. A dedicated technology transfer office manages IP, licensing, and collaboration agreements.